Cancer Clinical Trial
Official title:
Does Acupressure Help Reduce Nausea and Vomiting in Palliative Care Patients?
Randomised controlled trial of acupressure wrist bands for hospice in-patients suffering from terminal cancer who are troubled by nausea and vomiting.
Pilot The study will be piloted with 10 patients to ensure that the protocol is acceptable
to patients and to inform a formal power calculation for a larger study. Patients will be
randomized to each arm according to a randomization programme at www.randomization.com.
Arm 1 Instruction and placement of acupressure bands at the P6 acupuncture point
bilaterally. This point is located 2 cun (a Chinese measurement equal to approximately 3cm)
proximal to the midpoint of the transverse crease of the wrist between the tendons of
palmaris longus and flexor carpi radialis.
Arm 2 Instruction and placement of sham acupressure bands P6 acupuncture point bilaterally.
Sham acupressure bands have no stud to stimulate P6.
Patients may choose to have regular anti-emetics or a subcutaneous syringe driver after 24
hours if they are not happy with their level of nausea and vomiting.
4. STUDY POPULATION
4.1 Source and Number of Patients: Hospice in-patients. 10 patients for pilot.
4.2 Inclusion Criteria
Patients must meet the following criteria to be eligible to participate in the study:
1. Have a diagnosis of advanced cancer with an estimated prognosis of less than 1 year but
more than 3 days.
2. Describe their nausea as at least moderate on a Likert scale OR at have had at least
one vomit per day for the last three days.
3. Have an underlying cause for their nausea which is thought to be irreversible OR the
patient has made an autonomous choice not to proceed with treatment for any potentially
reversible cause (for example surgery for obstruction or drainage of ascites).
4. Can be male or female patients but must be over the age of 18.
5. Have signed a consent form prior to entering the study.
6. If patients are taking corticosteroids the dosage should be stable for 3 days before
and during the trial.
7. Be thought to be well enough to complete the 3 day trial.
4.3 Exclusion criteria
1. Arm lymphoedema.
2. Weakness, fatigue or confusion sufficient that patient is unable to take part.
3. Previous history of acupuncture/acupressure for nausea or vomiting.
4. History of Parkinsonism or Parkinsonism on examination.
5. Patients will not be enrolled if they are sharing a room with another patient taking
part in the study.
5. OUTCOME MEASURES
1. Visual Analogue Scale of nausea measured every 6 hours. If patients are asleep they
will not be waken for assessments overnight.
2. Duration of perceived nausea over preceding time period.
3. Number of vomits per 24 hours.
4. Volume of vomit per 24 hours.
5. Adverse effects of acupressure.
6. Number of doses of PRN anti-emetics.
7. Measure of whether the patient felt the intervention helped at the end of the trial.
6. QUANTITATIVE ANALYSIS
This pilot will allow a formal power calculation to be performed to elucidate how many
patients need to be randomized to the full study.
Statistical analysis will be performed by Sarah Vowler at the Centre for Applied Medical
Statistics.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|